IP Library Assignment 029959/0019
Patent Assignment
Reel/Frame 029959/0019

Change of Name

Recorded: 2013-03-11 Pages: 4
Assignor
SCHERING CORPORATION
Executed: 2012-05-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties (22)
NRIP1 Regulation of Apolipoprotein A1
Patent: 8,257,921 →
Application: 12/644,674 →
Exo- and Diastereo- Selective Synthesis of Himbacine Analogs
Patent: 8,258,319 →
Application: 13/168,029 →
Publication: US 2011/0251392
Benzenesulfonyl-Chromane, Thiochromane, Tetrahydronaphthalene and Related Gamma Secretase Inhibitors
Patent: 8,569,521 →
Application: 13/267,324 →
Publication: US 2012/0264736
Anti-Gitr Antibodies
Patent: 8,709,424 →
Application: 13/388,270 →
Publication: US 2012/0189639
Process for Preparing a 2-Alkynyl Substituted 5-Amino-Pyrazolo-[4,3-E]-1,2,4-Triazolo[1,5-C]Pyrimidine
Patent: 8,598,343 →
Application: 13/389,029 →
Publication: US 2012/0220769
Heterocyclic Amide Compounds as Protein Kinase Inhibitors
Patent: 8,669,259 →
Application: 13/391,402 →
Publication: US 2012/0208826
Modulators of Cell Cycle Checkpoints and Their Use in Combination with Checkpoint Kinase Inhibitors
Patent: 8,993,535 →
Application: 13/393,571 →
Publication: US 2012/0184505
Heterocyclic Aspartyl Protease Inhibitors
Patent: 8,691,833 →
Application: 13/415,404 →
Publication: US 2012/0231017
Heterocyclic Aspartyl Protease Inhibitors
Patent: 8,691,831 →
Application: 13/416,140 →
Publication: US 2012/0231018
Heterocyclic Aspartyl Protease Inhibitors
Patent: 8,829,036 →
Application: 13/420,007 →
Publication: US 2012/0276118
Aspartyl Protease Inhibitors
Patent: 8,629,155 →
Application: 13/421,396 →
Publication: US 2012/0232064
Ox2 Receptor Homologs
Application: 13/422,436 →
Publication: US 2012/0231003
Mdl-1 Uses
Application: 13/428,929 →
Publication: US 2012/0177647
Il-B30 Antibodies
Patent: 8,492,528 →
Application: 13/434,629 →
Publication: US 2012/0183964
FDF03 Antibodies and Uses Thereof
Application: 13/446,754 →
Publication: US 2012/0258110
A Method for Binding of CX3C Chemokines Using CX3C Chemokine Antibodies
Patent: 8,343,492 →
Application: 13/453,224 →
Publication: US 2012/0225482
Methods for Modulating Il-33 Activity
Application: 13/456,071 →
Publication: US 2012/0207752
Use of Il-27 Agonists to Increase Interferon-Gamma Production
Application: 13/471,242 →
Publication: US 2012/0225030
Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
Application: 13/471,250 →
Publication: US 2012/0276105
Novel Compounds That Are Erk Inhibitors
Patent: 8,658,651 →
Application: 13/496,964 →
Publication: US 2012/0214823
Substituted Piperidines That Increase P53 Activity and the Uses Thereof
Patent: 8,859,776 →
Application: 13/501,685 →
Publication: US 2012/0208844
April Antagonists and Methods of Use
Application: 13/501,702 →
Publication: US 2012/0201823
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 28, 2010
From: YAO, XIAORUI; ALTMANN, SCOTT W.; ZHU, LIJI
To: SCHERING CORPORATION
Reel/Frame 023860/0864 →
Assignment of Assignor's Interest Apr 4, 2012
From: POPOVICI-MULLER, JANETA; ROSNER, KRISTIN; GUZI, TIMOTHY J.
To: SCHERING CORPORATION
Reel/Frame 027988/0843 →
Assignment of Assignor's Interest Apr 12, 2012
From: REDDY, PANDURANGA ADULLA P.; SIDDIQUI, M. ARSHAD; WONG, TZU TSHIN
To: SCHERING CORPORATION
Reel/Frame 028036/0272 →
Assignment of Assignor's Interest Sep 16, 2016
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 039767/0695 →
Security Interest Sep 29, 2016
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PARTNERS, L.P.
Reel/Frame 039892/0309 →
Security Interest Aug 24, 2018
From: ARALEZ PHARMACEUTICAL TRADING DAC
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046696/0772 →
Corrective Assignment to Correct the Conveying Party Previously Recorded at Reel: 046696 Frame: 0772. Assignor(S) Hereby Confirms the Assignment. Aug 30, 2018
From: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046988/0741 →
Receiving Party/Assignee Address Change for Assignment Recorded at Reel/Frame 039767/0695 Aug 31, 2018
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 046989/0669 →
Assignment of Assignor's Interest Sep 10, 2020
From: TOPROL ACQUISITION LLC
To: XSPIRE PHARMA, LLC
Reel/Frame 053731/0376 →
Assignment of Assignor's Interest Oct 12, 2020
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: TOPROL ACQUISITION LLC
Reel/Frame 054027/0047 →
Merger Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →